본문 바로가기

Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
GYNECOLOGIC ONCOLOGY147(2) · pp.334 · 2017
피인용
Web of Science 15Scopus 19
FWCI (Scopus)
0.77
JCR IF
JCR 2016 4.959
ISSN
0090-8258

저자

  1. Lee, Sea-Won제1저자Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, South Korea
  2. Lee, Seok HoDepartment of Radiation Oncology, Gachon University of Medical and Science, Incheon, South Korea
  3. Kim, JureeDepartment of Radiation Oncology, Cheil General Hospital, Dankook University College of Medicine, Seoul, South Korea
  4. Kim, Yeon-SilDepartment of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, South Korea
  5. Yoon, Mee SunDepartment of Radiation Oncology, Hwasun Chonnam National University Hospital, Hwasun, South Korea
  6. Jeong, SongmiDepartment of Radiation Oncology, Ewha Woman's University School of Medicine, Seoul, South Korea
  7. Kim, Jin HeeDepartment of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea
  8. 이자영Department of Radiation Oncology, Pusan National University Yangsan Hospital, Yangsan, South Korea
  9. Eom, Keun-YongDepartment of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam-si, South Korea
  10. Jeong, Bae KwonDepartment of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, South Korea
  11. Sung, Soo YoonDepartment of Radiation Oncology, St. Vincent's Hospital, College of Medicine, the Catholic University of Korea, Suwon, South Korea
  12. Lee, Sung JongDepartment of Obstetrics and Gynecology, St. Vincent's Hospital, College of Medicine, the Catholic University of Korea, Suwon, South Korea
  13. Lee, Jong Hoon교신저자Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, the Catholic University of Korea, Suwon, South Korea

초록

Objective. Definitive chemoradiotherapy (CRT) followed by brachytherapy is a standard treatment for locally advanced cervical cancer. During CRT, marked reduction of cervical tumor is often observed in magnetic resonance imaging (MRI). The primary aim of this study was to assess the association between tumor response in MRI using FIGO classification and clinical outcomes. Methods. Multi-institutional data were retrospectively reviewed to identify the significance of MR tumor response on tumor recurrence and patient survival. 225 patients with histologically confirmed squamous cell carcinoma of the cervix, staged as FIGO1b2-1Va on initial pelvic MRI, were included. Post-CRT MRI was performed median 35 days after the beginning of CRT and before brachytherapy. A median 54 Gy of external radiation was given with weekly cisplatin during CRT. Results. 112 (49.7%) of the 225 patients showed a positive response in post-CRT MRI and were named the responsive arm. After a median follow-up time of 36.2 months, the responsive arm had significantly lower paraaortic recurrence (7.5% vs. 12.4%; p = 0.04) and distant metastasis (13.2% vs. 27.6%; p = 0.03) rates than did the non-responsive arm. The responsive arm had significantly higher 3-year cause-specific survival rate (94.6% vs. 81.1%, p < 0.01) than did the non-responsive arm. In the multivariate analysis, tumor size (hazard ratio, 1.91 and 95% confidence interval, 1.07-3.43; p = 0.028) and positive MR response (hazard ratio, 1.75 and 95% confidence interval, 1.06-2.27; p = 0.045) were significant factors for recurrence-free survival Conclusion. Early tumor response evaluation with MRI using FIGO classification effectively predicted distant tumor metastasis and disease-specific survival in locally advanced cervical cancer. (c) 2017 Elsevier Inc. All rights reserved.

키워드

Cervical cancerChemoradiotherapyEarly responseMRICONCURRENT CHEMORADIOTHERAPYTREATMENT RESPONSEVOLUME RESPONSERADIOTHERAPYREGRESSIONEXPRESSIONCARCINOMARADIATION

식별자

Scopus EID
2-s2.0-85029490475
WoS UID
000415663600017